SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on July 12, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut. The filing discloses a Regulation FD event regarding the conclusion of the company's PURE EP 2.0 study.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than periodic financial performance.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The primary event is the announcement of a conference call to discuss the recent conclusions of the PURE EP 2.0 study.
Guidance, Outlook, and Risks
Management announced a call to discuss study conclusions but explicitly undertook no obligation to update, supplement, or amend the attached materials. The filing includes standard disclaimers stating that the information is not deemed "filed" for Section 18 liability purposes under the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Key Facts for Investor Verification
- Verify the specific outcomes and data points of the PURE EP 2.0 study discussed in the referenced press release (Exhibit 99.1).
- Confirm the date and time of the conference call announced to discuss the study conclusions.
- Note that the information provided is not incorporated by reference into other Exchange Act filings unless expressly stated.
- Check subsequent filings for any updates or amendments to the study conclusions, as the company disclaimed an obligation to update this specific report.